Results 1 - 10 of 10 for IBRITUMOMAB TIUXETAN
  1. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hycamtin (Topotecan Hydrochloride) Hyper-CVAD I Ibrance (Palbociclib) Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Idamycin (Idarubicin Hydrochloride) ...
  2. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    ... Hydrochloride Folex (Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Ibritumomab Tiuxetan Ibrutinib Idelalisib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon ...
  3. Radioimmunotherapy (American College of Radiology) (Radiological Society of North America)  
    ... tumor. The agent used today is Yttrium-90 Ibritumomab Tiuxetan ( Zevalin ®). Iodine-131 Tositumomab ( Bexxar ®) is no longer ... special precautions will be needed for Yttrium-90 Ibritumomab Tiuxetan (Zevalin®). top of page How is the procedure ...
  4. Mantle Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... combined with a radioisotope such as yttrium-90 ibritumomab tiuxetan (Zevalin®). Zevalin, given intravenously, is FDA approved for ...
  5. List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012 (Centers for Disease Control and Prevention) - PDF  
    ... 2,3,4,5 10:00 Antineoplastic agents Ibritumomab tiuxetan 3 10:00 Antineoplastic agents Idarubicin 1,2, ...
  6. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... ceritinib (LDK378/Zykadia) , ramucirumab (Cyramza®) , nivolumab (Opdivo®) Lymphoma: Ibritumomab tiuxetan (Zevalin®) , denileukin diftitox (Ontak®) , brentuximab vedotin (Adcetris®) , rituximab ( ...
  7. Marginal Zone Lymphoma (Lymphoma Research Foundation) - PDF  
    ... growing lymphomas, including: • B-cell receptor signaling blockers • Ibritumomab tiuxetan (Zevalin) It is critical to remember that today’s ...
  8. Radiation Therapy for Cancer From the National Institutes of Health (National Cancer Institute)  
    ... and killing tumor cells. For example: The drug ibritumomab tiuxetan (Zevalin®) has been approved by the Food and ...
  9. Biological Therapies for Cancer From the National Institutes of Health (National Cancer Institute)  
    ... MAbs that work this way include 90 Y- ibritumomab tiuxetan , which targets the CD20 antigen to deliver radioactive ...
  10. ... treatment used for follicular lymphoma is 90 Y-ibritumomab tiuxetan (brand name: Zevalin), which is given through a ...
Refine by Type
  • All Results (10)
  • Health Topics
  •  External Health Links (10)
  • Drugs and Supplements
  • Medical Encyclopedia
  • Videos and Tutorials
  • News
  • MedlinePlus Magazine
  • Other Resources
  • Multiple Languages